Skip to main content
. 2021 Feb 4;2021(2):CD013052. doi: 10.1002/14651858.CD013052.pub2

Comparison 1. Systemic antibiotics versus no treatment/placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Resolution of ear discharge at 1 to 2 weeks  1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.1.1 Any antibiotic (mezlocillin or ceftazidime) 1 33 Risk Ratio (M‐H, Fixed, 95% CI) 8.47 [1.88, 38.21]
1.1.2 Mezlocillin 1 22 Risk Ratio (M‐H, Fixed, 95% CI) 8.27 [1.83, 37.47]
1.1.3 Ceftazidime 1 23 Risk Ratio (M‐H, Fixed, 95% CI) 8.31 [1.84, 37.59]